Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
869 | 10864 | 35.2 | 78% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
525 | 17362 | LIPODYSTROPHY//PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
742 | 3034 | LIPODYSTROPHY//LIPOATROPHY//PROGRAM NUTR METAB |
4856 | 1643 | HIV ASSOCIATED NEPHROPATHY//TENOFOVIR//HIVAN |
10633 | 980 | MICROBIAL TRANSLOCATION//HIV ENTEROPATHY//ISOSPORA BELLI |
11309 | 925 | CYTOMEGALOVIRUS COLITIS//CYTOMEGALOVIRUS ENTERITIS//CMV COLITIS |
13398 | 775 | HIV WASTING//HIV WASTING SYNDROME//WASTING |
14809 | 679 | ESOPHAGEAL CANDIDIASIS//ESOPHAGEAL TUBERCULOSIS//AIDS CLIN ACC |
15146 | 659 | HIV RELATED PULMONARY HYPERTENSION//HIV ASSOCIATED CARDIOMYOPATHY//CA2M |
16213 | 600 | METROPOLITAN VASC SERV//RHEUMATIC MANIFESTATIONS//HIV ARTHRITIS |
16742 | 574 | HIV MOL GRP//MED INT MED INFECT DIS//BODY COMPOSIT ANAL |
16835 | 568 | AIDS CHOLANGIOPATHY//ANAL DISEASES//ANAL ULCER |
19753 | 427 | 1200 N STATE ST//ADRENAL RESERVE//ADRENOCORTICAL DYSFUNCTION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIPODYSTROPHY | Author keyword | 338 | 54% | 4% | 439 |
2 | HIV ASSOCIATED NEPHROPATHY | Author keyword | 110 | 78% | 1% | 72 |
3 | LIPOATROPHY | Author keyword | 82 | 53% | 1% | 110 |
4 | TENOFOVIR | Author keyword | 81 | 32% | 2% | 212 |
5 | PROGRAM NUTR METAB | Address | 74 | 62% | 1% | 76 |
6 | HIV INFECTION | Author keyword | 70 | 13% | 5% | 509 |
7 | ANTIRETROVIRAL THERAPY | Author keyword | 68 | 12% | 5% | 521 |
8 | HIV ASSOCIATED LIPODYSTROPHY SYNDROME | Author keyword | 50 | 88% | 0% | 23 |
9 | FAT REDISTRIBUTION | Author keyword | 47 | 79% | 0% | 30 |
10 | MICROBIAL TRANSLOCATION | Author keyword | 45 | 55% | 1% | 57 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPODYSTROPHY | 338 | 54% | 4% | 439 | Search LIPODYSTROPHY | Search LIPODYSTROPHY |
2 | HIV ASSOCIATED NEPHROPATHY | 110 | 78% | 1% | 72 | Search HIV+ASSOCIATED+NEPHROPATHY | Search HIV+ASSOCIATED+NEPHROPATHY |
3 | LIPOATROPHY | 82 | 53% | 1% | 110 | Search LIPOATROPHY | Search LIPOATROPHY |
4 | TENOFOVIR | 81 | 32% | 2% | 212 | Search TENOFOVIR | Search TENOFOVIR |
5 | HIV INFECTION | 70 | 13% | 5% | 509 | Search HIV+INFECTION | Search HIV+INFECTION |
6 | ANTIRETROVIRAL THERAPY | 68 | 12% | 5% | 521 | Search ANTIRETROVIRAL+THERAPY | Search ANTIRETROVIRAL+THERAPY |
7 | HIV ASSOCIATED LIPODYSTROPHY SYNDROME | 50 | 88% | 0% | 23 | Search HIV+ASSOCIATED+LIPODYSTROPHY+SYNDROME | Search HIV+ASSOCIATED+LIPODYSTROPHY+SYNDROME |
8 | FAT REDISTRIBUTION | 47 | 79% | 0% | 30 | Search FAT+REDISTRIBUTION | Search FAT+REDISTRIBUTION |
9 | MICROBIAL TRANSLOCATION | 45 | 55% | 1% | 57 | Search MICROBIAL+TRANSLOCATION | Search MICROBIAL+TRANSLOCATION |
10 | LIPODYSTROPHY SYNDROME | 38 | 84% | 0% | 21 | Search LIPODYSTROPHY+SYNDROME | Search LIPODYSTROPHY+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPODYSTROPHY | 326 | 45% | 5% | 548 |
2 | FAT REDISTRIBUTION | 225 | 92% | 1% | 90 |
3 | PROTEASE INHIBITORS | 167 | 17% | 8% | 883 |
4 | PERIPHERAL LIPODYSTROPHY | 156 | 75% | 1% | 113 |
5 | LIPODYSTROPHY SYNDROME | 150 | 73% | 1% | 114 |
6 | ANTIRETROVIRAL THERAPY | 148 | 11% | 12% | 1327 |
7 | ACTIVE ANTIRETROVIRAL THERAPY | 148 | 11% | 11% | 1243 |
8 | HIV 1 ASSOCIATED NEPHROPATHY | 124 | 90% | 0% | 54 |
9 | INFECTED PATIENTS | 119 | 15% | 7% | 744 |
10 | INHIBITOR ASSOCIATED LIPODYSTROPHY | 106 | 85% | 1% | 56 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HIV MEDICINE | 36 | 18% | 2% | 179 |
2 | HIV CLINICAL TRIALS | 17 | 18% | 1% | 84 |
3 | AIDS REVIEWS | 4 | 13% | 0% | 31 |
4 | AIDS RESEARCH AND THERAPY | 4 | 12% | 0% | 28 |
5 | AIDS READER | 3 | 16% | 0% | 17 |
6 | CURRENT HIV/AIDS REPORTS | 2 | 12% | 0% | 20 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Stimulating High Impact HIV-Related Cardiovascular Research Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease | 2015 | 2 | 42 | 81% |
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review | 2006 | 299 | 36 | 86% |
The end of AIDS: HIV infection as a chronic disease | 2013 | 99 | 82 | 32% |
Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America | 2005 | 332 | 167 | 70% |
Microbial translocation in HIV infection: causes, consequences and treatment opportunities | 2012 | 93 | 150 | 42% |
Microbial Translocation in the Pathogenesis of HIV Infection and AIDS | 2013 | 54 | 133 | 43% |
Review article: cytomegalovirus and inflammatory bowel disease | 2015 | 1 | 43 | 84% |
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence | 2011 | 82 | 57 | 65% |
HIV infection and cardiovascular disease | 2014 | 9 | 75 | 80% |
Skeletal health in adults with HIV infection | 2015 | 1 | 103 | 81% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROGRAM NUTR METAB | 74 | 62% | 0.7% | 76 |
2 | HIV MOL GRP | 21 | 71% | 0.2% | 17 |
3 | NUTR INFECT UNIT | 14 | 55% | 0.2% | 17 |
4 | AHOD | 11 | 100% | 0.1% | 6 |
5 | HIV IMMUNOL INFECT DIS CLIN SERV UNIT | 9 | 34% | 0.2% | 22 |
6 | TRANSLAT METAB UNIT | 8 | 42% | 0.1% | 15 |
7 | CPCRA | 8 | 100% | 0.0% | 5 |
8 | HIV UNIT | 7 | 14% | 0.4% | 46 |
9 | DENVER COMMUNITY PROGRAMS CLIN AIDS | 6 | 80% | 0.0% | 4 |
10 | EUROSIDA | 6 | 80% | 0.0% | 4 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000014871 | ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE |
2 | 0.0000009026 | PNEUMOCYSTIS CARINII//PNEUMOCYSTIS JIROVECII//PNEUMOCYSTIS CARINII PNEUMONIA |
3 | 0.0000008266 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
4 | 0.0000007115 | MICROSPORIDIA//ENCEPHALITOZOON CUNICULI//ENTEROCYTOZOON BIENEUSI |
5 | 0.0000006992 | IMMUNOSENESCENCE//NUTRIENT MIXTURE//IMMUNITY & AGEING |
6 | 0.0000006850 | CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HHV 6 |
7 | 0.0000005400 | CRYPTOSPORIDIUM//CRYPTOSPORIDIUM PARVUM//EIMERIA |
8 | 0.0000005178 | ARTIFICIAL URINARY SPHINCTER//VESICO URETERAL REFLUX//URINARY SPHINCTER ARTIFICIAL |
9 | 0.0000003615 | IMMUNE THROMBOCYTOPENIA//IDIOPATHIC THROMBOCYTOPENIC PURPURA//IMMUNE THROMBOCYTOPENIC PURPURA |
10 | 0.0000003613 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |